Literature DB >> 24105664

Relapses in the treatment of genotype 2 viral hepatitis C, a cause of concern in the blacks.

O Njoya1, L Ntchama, M Tagni, I Dang, M Kowo.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24105664     DOI： 10.1007/s12664-013-0385-3

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  2 in total

1.  High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon.

Authors:  Richard Njouom; Christophe Pasquier; Ahidjo Ayouba; Antoine Gessain; Alain Froment; Jermie Mfoupouendoun; Regis Pouillot; Martine Dubois; Karine Sandres-Sauné; Jocelyn Thonnon; Jacques Izopet; Eric Nerrienet
Journal:  J Med Virol       Date:  2003-10       Impact factor: 2.327

2.  Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C.

Authors:  Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tchendjou; Christophe Pasquier; Dominique Rousset
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327
  2 in total
  2 in total

1.  Hepatitis C in Cameroon: What is the progress from 2001 to 2016?

Authors:  Borris Rosnay Tietcheu Galani; Richard Njouom; Paul Fewou Moundipa
Journal:  J Transl Int Med       Date:  2016-12-30

2.  Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro.

Authors:  Borris R T Galani; Marie-Emmanuelle Sahuc; Frederic N Njayou; Gaspard Deloison; Pierre Mkounga; William F Feudjou; Priscille Brodin; Yves Rouillé; Augustin E Nkengfack; Paul Fewou Moundipa; Karin Séron
Journal:  Front Microbiol       Date:  2015-05-15       Impact factor: 5.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.